How do we manage our 4-year-old nephew’s Hemophilia A?

Question

Hello doctor,

My 4-year-old nephew was diagnosed with hemophilia A (factor VIII less than one percent) after excessive bleeding following a minor fall. The hematologist mentioned prophylactic factor therapy, but my sister is worried about needle burden and possible inhibitor development.

Is there a safer alternative, like gene therapy or subcutaneous medication, for young kids?
How should we manage routine vaccinations or dental care
Do they need to be done in a hospital setting?
Are school activities like sports completely off-limits for my nephew?

Kindly help.

Answer 1

Hello,

Welcome to icliniq.com.

I read your query and can understand your concern.

Your nephew has been diagnosed with Hemophilia A, and with a factor VIII activity level below one percent, he is suffering from severe Hemophilia A.

The recommended treatment for children with severe Hemophilia A involves prophylactic factor VIII replacement therapy. This is usually started early to prevent joint damage and spontaneous bleeding. However, the frequent intravenous infusions can be difficult, particularly for young children with small veins, so your sister's concerns are completely valid.

Additionally, one of the major challenges in early treatment is the potential for developing inhibitors, antibodies that neutralize factor VIII, rendering it less effective. These inhibitors occur in approximately 20–30 percent of children with severe Hemophilia A, typically within the first 50 days of exposure. Regular monitoring and consistent use of products can help to lower such risk.

Emicizumab (medicine for hemophilia A) is a subcutaneous medication that mimics the function of factor VIII. While it is not a gene therapy or a traditional clotting factor, it significantly reduces bleeding and can be administered once a month. It has been approved for use in children, both with and without inhibitors, including very young ones. For many children, this treatment option greatly lessens the burden of needles and enhances quality of life. Nevertheless, the choice between Emicizumab and conventional factor therapy should be based on the patient's condition.

Also, gene therapy is currently being investigated as a more permanent solution for Hemophilia A. Although early results in adults are encouraging, it has not yet received approval for children due to safety concerns, long-term effectiveness, and the fact that children's livers are still developing, which may impact the therapy's efficacy over time. Ongoing medical research continues to address these issues.

Regarding routine vaccinations, your nephew should definitely receive them, but with additional precautions. Vaccines are usually administered intramuscularly, which can heighten the risk of muscle bleeds. Dental care is important for oral health. Routine cleanings are typically safe, but for any invasive dental procedures, such as extractions, your nephew should receive factor replacement both before and after the treatment.

Regarding school and physical activities, sports are not completely off-limits; however, contact sports like football, wrestling, or rugby are usually discouraged due to the high risk of injury and internal bleeding. Many children with hemophilia can safely engage in activities like swimming, walking, cycling, and even some martial arts with supervision. You have to remember that the aim is to promote physical activity to strengthen joints and support a normal social life, always with personalized guidance from their care team.

I hope this information helps you.

Feel free to ask further queries.